Gemma Collins weight-loss drug advert banned
UNITED KINGDOM, JUL 9 – Advertising Standards Authority banned nine ads including Gemma Collins' for promoting prescription-only weight-loss drugs illegally, following over 1,800 flagged ads in a broad crackdown.
- The ASA banned nine weight-loss drug ads this week, including one with Gemma Collins, for promoting prescription-only medications unlawfully.
- Under UK advertising laws, the ASA banned around 1,800 online ads promoting prescription-only weight-loss drugs like Wegovy and Mounjaro after a January review found illegal promotions.
- Beyond Collins' case, eight healthcare firms including CheqUp and pharmacyonline.co.uk had their ads banned across platforms like Instagram and Meta for promoting prescription-only weight-loss medications illegally.
- Following the ASA’s recent bans, Yazen Health has been warned not to promote prescription-only weight-loss drugs, setting a clear industry enforcement precedent.
- Regulators have issued a joint Enforcement Notice with MHRA and GPhC, with CMA powers to investigate and fine ongoing illegal health ads, signaling intensified oversight.
Insights by Ground AI
Does this summary seem wrong?
29 Articles
29 Articles
Gemma Collins breaks cover as she issues first social media statement since weight loss drug advert banned
Gemma Collins has returned to Instagram with a lengthy post following the Advertising Standards Authority's decision to ban nine weight-loss drug adverts in a major crackdown on illegal promotion of prescription-only medications to the public
·London, United Kingdom
Read Full ArticleGemma Collins: Ex-TOWIE star's weight-loss drug Instagram advert banned as watchdog cracks down
Reality TV star Gemma Collins has had an advert on her Instagram banned by the Advertisting Standards Agency (ASA) after she promoted prescription-only weight-loss medication to more than two million followers.
Coverage Details
Total News Sources29
Leaning Left4Leaning Right2Center12Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 22%
C 67%
11%
Factuality
To view factuality data please Upgrade to Premium